cd80 pe Search Results


94
Multi Sciences (Lianke) Biotech Co Ltd anti mouse cd80
Anti Mouse Cd80, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd80/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 94 stars, based on 1 article reviews
anti mouse cd80 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology anti mouse cd80
a <t>CD80</t> and CD86 levels of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). b Quantification of the proportion of CD80 + CD86 + BMDCs. c MHC-I level of BMDCs indicated by flow cytometry (The gating strategy was shown in the Supplementary Fig. ). d Quantification of the proportion of MHC-I + BMDCs. e MHC-II level of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). f Quantification of MHC-II + BMDCs. g CFDA-SE level in CD3 + T cells (The gating strategy was shown in the Supplementary Fig. ). h Quantification of T cell proliferation rate. i CLSM images of infiltrated CD8a + T cells into Hepa1-6 cell spheroids. j Quantification of T cell infiltration.
Anti Mouse Cd80, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd80/product/Elabscience Biotechnology
Average 94 stars, based on 1 article reviews
anti mouse cd80 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Cytek Biosciences cd80
a <t>CD80</t> and CD86 levels of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). b Quantification of the proportion of CD80 + CD86 + BMDCs. c MHC-I level of BMDCs indicated by flow cytometry (The gating strategy was shown in the Supplementary Fig. ). d Quantification of the proportion of MHC-I + BMDCs. e MHC-II level of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). f Quantification of MHC-II + BMDCs. g CFDA-SE level in CD3 + T cells (The gating strategy was shown in the Supplementary Fig. ). h Quantification of T cell proliferation rate. i CLSM images of infiltrated CD8a + T cells into Hepa1-6 cell spheroids. j Quantification of T cell infiltration.
Cd80, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd80/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
cd80 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Cedarlane anti mouse cd80
Comparison of DC function in TNF-α+/+ and TNF-α−/− mice. CD11c+ cell separation was carried out by using the VarioMACS system. (A) Flow cytometric analysis of the expression of the MHC-I molecule H-2Ld (restriction element for HBsAg-specific CTL), the MHC-II molecule I-A/I-E, <t>CD80,</t> and CD86 in TNF-α+/+ and TNF-α−/− DCs. All samples were assayed in duplicate. (B) The allostimulatory capacity of CD11c+ DCs from TNF-α+/+ and TNF-α−/− mice was assessed by the MLR as described in Materials and Methods with allogeneic murine CD4+ T cells from AKR mice (H-2k). Each data point and error bar represent the mean and SD, respectively, of results for triplicate samples.
Anti Mouse Cd80, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd80/product/Cedarlane
Average 93 stars, based on 1 article reviews
anti mouse cd80 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology cd80 antibody
Comparison of DC function in TNF-α+/+ and TNF-α−/− mice. CD11c+ cell separation was carried out by using the VarioMACS system. (A) Flow cytometric analysis of the expression of the MHC-I molecule H-2Ld (restriction element for HBsAg-specific CTL), the MHC-II molecule I-A/I-E, <t>CD80,</t> and CD86 in TNF-α+/+ and TNF-α−/− DCs. All samples were assayed in duplicate. (B) The allostimulatory capacity of CD11c+ DCs from TNF-α+/+ and TNF-α−/− mice was assessed by the MLR as described in Materials and Methods with allogeneic murine CD4+ T cells from AKR mice (H-2k). Each data point and error bar represent the mean and SD, respectively, of results for triplicate samples.
Cd80 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd80 antibody/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
cd80 antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology pe cyanine7 anti mouse cd80
Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of <t>CD80,</t> CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.
Pe Cyanine7 Anti Mouse Cd80, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe cyanine7 anti mouse cd80/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
pe cyanine7 anti mouse cd80 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Cytek Biosciences 50 0801 u025 cd86 bv605
Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of <t>CD80,</t> CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.
50 0801 U025 Cd86 Bv605, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/50 0801 u025 cd86 bv605/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
50 0801 u025 cd86 bv605 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Cytek Biosciences cd80 pe cy7
Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of <t>CD80,</t> CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.
Cd80 Pe Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd80 pe cy7/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
cd80 pe cy7 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Proteintech pe anti mouse cd80 proteintech pe
Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of <t>CD80,</t> CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.
Pe Anti Mouse Cd80 Proteintech Pe, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe anti mouse cd80 proteintech pe/product/Proteintech
Average 93 stars, based on 1 article reviews
pe anti mouse cd80 proteintech pe - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
R&D Systems pe anti human cd80
Comparison of the phenotypic profiles of DCLCs primed with or without IFIT4 over-expression. (a) Surface antigens of normal THP-1 cells were examined by flow cytometry. (b) To analyze the effect of IFIT4 on phenotypic changes of dendritic cell-like cells (DCLCs) during the process of differentiation, THP-1 cells were transfected with pEGFP-IFIT4 or pEGFP-C1; 36 hours later, cells were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF; 50 ng/ml) and IL-4 (20 ng/ml) for 90 hours to generate DCLCs. These DCLCs primed with pEGFP-IFIT4 or pEGFP-C1 transfection were incubated with fluorochrome-conjugated monoclonal antibodies (mAbs) and the antigens of CD40, <t>CD80,</t> CD86, CD83, HLA-DR, CD14 and CD1a on the surface of those DCLCs were analyzed by flow cytometry. Appropriate fluorochrome or isotype control mAbs of each antibody species were used as negative controls. Shaded histograms represent isotype control antibodies. The thick line represents DCLCs primed with pEGFP-IFIT4 transfection, whereas the slender lines represent DCLCs primed with pEGFP-C1 transfection. All experiments were performed three times and a set of representative histograms was presented. IFIT4, interferon-induced protein with tetratricopeptide repeats 4.
Pe Anti Human Cd80, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe anti human cd80/product/R&D Systems
Average 93 stars, based on 1 article reviews
pe anti human cd80 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
R&D Systems cd80
Comparison of the phenotypic profiles of DCLCs primed with or without IFIT4 over-expression. (a) Surface antigens of normal THP-1 cells were examined by flow cytometry. (b) To analyze the effect of IFIT4 on phenotypic changes of dendritic cell-like cells (DCLCs) during the process of differentiation, THP-1 cells were transfected with pEGFP-IFIT4 or pEGFP-C1; 36 hours later, cells were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF; 50 ng/ml) and IL-4 (20 ng/ml) for 90 hours to generate DCLCs. These DCLCs primed with pEGFP-IFIT4 or pEGFP-C1 transfection were incubated with fluorochrome-conjugated monoclonal antibodies (mAbs) and the antigens of CD40, <t>CD80,</t> CD86, CD83, HLA-DR, CD14 and CD1a on the surface of those DCLCs were analyzed by flow cytometry. Appropriate fluorochrome or isotype control mAbs of each antibody species were used as negative controls. Shaded histograms represent isotype control antibodies. The thick line represents DCLCs primed with pEGFP-IFIT4 transfection, whereas the slender lines represent DCLCs primed with pEGFP-C1 transfection. All experiments were performed three times and a set of representative histograms was presented. IFIT4, interferon-induced protein with tetratricopeptide repeats 4.
Cd80, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd80/product/R&D Systems
Average 94 stars, based on 1 article reviews
cd80 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
Proteintech pe anti human cd80 b7 1
Fig.2 Expression of TPX2 in A549 cells affects macrophage polarization. (A) Detection of macrophage surface markers <t>CD80</t> and CD163 after cell supernatant induction in A549 group, Vehicle group and TPX2-shRNA group. (B) The analysis percentage of macrophage surface marker CD80, CD163; CD80/CD163 after induction by cell supernatant of the three groups. (C) CD80 and CD163 protein expression in macrophages after induction in the supernatant of the three groups cells. (D) The
Pe Anti Human Cd80 B7 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe anti human cd80 b7 1/product/Proteintech
Average 92 stars, based on 1 article reviews
pe anti human cd80 b7 1 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

Image Search Results


a CD80 and CD86 levels of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). b Quantification of the proportion of CD80 + CD86 + BMDCs. c MHC-I level of BMDCs indicated by flow cytometry (The gating strategy was shown in the Supplementary Fig. ). d Quantification of the proportion of MHC-I + BMDCs. e MHC-II level of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). f Quantification of MHC-II + BMDCs. g CFDA-SE level in CD3 + T cells (The gating strategy was shown in the Supplementary Fig. ). h Quantification of T cell proliferation rate. i CLSM images of infiltrated CD8a + T cells into Hepa1-6 cell spheroids. j Quantification of T cell infiltration.

Journal: NPJ Vaccines

Article Title: A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma

doi: 10.1038/s41541-024-01060-2

Figure Lengend Snippet: a CD80 and CD86 levels of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). b Quantification of the proportion of CD80 + CD86 + BMDCs. c MHC-I level of BMDCs indicated by flow cytometry (The gating strategy was shown in the Supplementary Fig. ). d Quantification of the proportion of MHC-I + BMDCs. e MHC-II level of BMDCs in flow cytometry (The gating strategy was shown in the Supplementary Fig. ). f Quantification of MHC-II + BMDCs. g CFDA-SE level in CD3 + T cells (The gating strategy was shown in the Supplementary Fig. ). h Quantification of T cell proliferation rate. i CLSM images of infiltrated CD8a + T cells into Hepa1-6 cell spheroids. j Quantification of T cell infiltration.

Article Snippet: Cells were subsequently stained with APC-conjugated anti-mouse CD11c, FITC-conjugated anti-mouse CD80, and PE-conjugated anti-mouse CD86 antibodies (Elabscience, China) for flow cytometry analysis (Beckman, USA).

Techniques: Flow Cytometry

a Scheme illustration of in vivo treatment and monitoring (Created by the authors with Photoshop v22.5.6). b Bioluminescence images of tumor-bearing mice in different groups. c Relative signal intensity of tumors in different groups. d Body weight of the mice in different groups. e Flow cytometry analyzing CD80 and CD86 in CD11c + dendritic cells in mouse inguinal lymph nodes (Gating strategy was shown in the Supplementary Fig. ). f Quantification of the percentage of CD80 + CD86 + cells in CD11c + dendritic cells. g Flow cytometry analyzing CD8a and CD4 of T cells (CD45 + CD3 + ) in tumor tissues (Gating strategy was shown in the Supplementary Fig. ). h Quantification of the percentage of CD8a + cells in T cells.

Journal: NPJ Vaccines

Article Title: A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma

doi: 10.1038/s41541-024-01060-2

Figure Lengend Snippet: a Scheme illustration of in vivo treatment and monitoring (Created by the authors with Photoshop v22.5.6). b Bioluminescence images of tumor-bearing mice in different groups. c Relative signal intensity of tumors in different groups. d Body weight of the mice in different groups. e Flow cytometry analyzing CD80 and CD86 in CD11c + dendritic cells in mouse inguinal lymph nodes (Gating strategy was shown in the Supplementary Fig. ). f Quantification of the percentage of CD80 + CD86 + cells in CD11c + dendritic cells. g Flow cytometry analyzing CD8a and CD4 of T cells (CD45 + CD3 + ) in tumor tissues (Gating strategy was shown in the Supplementary Fig. ). h Quantification of the percentage of CD8a + cells in T cells.

Article Snippet: Cells were subsequently stained with APC-conjugated anti-mouse CD11c, FITC-conjugated anti-mouse CD80, and PE-conjugated anti-mouse CD86 antibodies (Elabscience, China) for flow cytometry analysis (Beckman, USA).

Techniques: In Vivo, Flow Cytometry

Comparison of DC function in TNF-α+/+ and TNF-α−/− mice. CD11c+ cell separation was carried out by using the VarioMACS system. (A) Flow cytometric analysis of the expression of the MHC-I molecule H-2Ld (restriction element for HBsAg-specific CTL), the MHC-II molecule I-A/I-E, CD80, and CD86 in TNF-α+/+ and TNF-α−/− DCs. All samples were assayed in duplicate. (B) The allostimulatory capacity of CD11c+ DCs from TNF-α+/+ and TNF-α−/− mice was assessed by the MLR as described in Materials and Methods with allogeneic murine CD4+ T cells from AKR mice (H-2k). Each data point and error bar represent the mean and SD, respectively, of results for triplicate samples.

Journal:

Article Title: Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes

doi: 10.1128/JVI.77.4.2469-2476.2003

Figure Lengend Snippet: Comparison of DC function in TNF-α+/+ and TNF-α−/− mice. CD11c+ cell separation was carried out by using the VarioMACS system. (A) Flow cytometric analysis of the expression of the MHC-I molecule H-2Ld (restriction element for HBsAg-specific CTL), the MHC-II molecule I-A/I-E, CD80, and CD86 in TNF-α+/+ and TNF-α−/− DCs. All samples were assayed in duplicate. (B) The allostimulatory capacity of CD11c+ DCs from TNF-α+/+ and TNF-α−/− mice was assessed by the MLR as described in Materials and Methods with allogeneic murine CD4+ T cells from AKR mice (H-2k). Each data point and error bar represent the mean and SD, respectively, of results for triplicate samples.

Article Snippet: To evaluate the expression intensities of MHC and costimulatory molecules, mouse or rat biotin-conjugated anti-mouse MHC-I ( H - 2L d ), MHC-II ( I - A d / I - E d ), PE-labeled streptavidin (BD PharMingen), rat PE-conjugated anti-mouse CD80 and CD86 (Cedarlane, Ontario, Canada) were used for staining.

Techniques: Expressing

Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of CD80, CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Stem cell research & therapy

Article Title: Migrasomes derived from human umbilical cord mesenchymal stem cells: a new therapeutic agent for ovalbumin-induced asthma in mice.

doi: 10.1186/s13287-025-04145-4

Figure Lengend Snippet: Fig. 3 Administration of hUCMSC-migrasomes diminished Th2 response in allergic asthma by suppressing DC maturation. A The expression of IL-4, IL-5 and IL-13 in the lung of mice in each group were detected by real-time PCR (n = 6). B Gating strategy and representative flow cytometric images for the analysis of CD45+CD4+CCR4+CXCR3− Th2 cells in the lungs of mice from each group. C Graphs showing the % of CD45+CD4+CCR4+CXCR3−Th2 cells in the lungs of mice from each group (n = 6). D Gating strategy and representative flow cytometric dot plots (left) for the analysis of CD11b+ DCs in the lungs of allergic mice and the numbers of CD11b+ DCs (right) in the lungs of mice from each group (n = 6). E The mean MFI of CD80, CD86 and MHC-II on CD11b+ DCs (n = 4–6). F The expression of IL-6 in the lung of mice were detected by real-time PCR (n = 6). G Distribution of Dir-labeled migrasomes in OVA-induced mice lung after tail vein administration (17-day injection and 18-day detected). H Representative immunofluorescence images of Dil-labeled migrasomes (red) taken up by CD11c+ cells or CD4+ cells. Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was per formed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: The cell pellets were then stained with a range of monoclonal antibodies including FITC anti-mouse CD45 (eBioscience, San Diego, CA), eflour 450 anti-mouse CD4 (eBioscience), PE- anti-mouse CCR4 (Biolegend), APC anti-mouse CXCR3 (Biolegend), eflour 450 anti-mouse CD11c (eBioscience), FITC anti-mouse CD11b (Elabscience, Wuhan, China), PE/Cyanine7 anti-mouse CD80 (Elabscience), PE anti-mouse CD86 (eBioscience) and APC anti-mouse MHC-II (eBioscience).

Techniques: Expressing, Real-time Polymerase Chain Reaction, Labeling, Injection, Immunofluorescence

Fig. 4 HUCMSC-migrasomes impaired DC maturation and function in vitro. A BMDCs incubated with Dil-labeled migrasomes under fluorescence micro scope (white bar = 25 μm). B The cell viability of BMDCs treated by hUCMSC-migrasomes for 24 h (left) and 48 h (right) (n = 4). C BMDCs were isolated from wild-type BALB/c mice and cultured at a density of 2 × 10⁵ cells/mL. The cells were stimulated with OVA (100 µg/mL) and LPS (10 ng/mL) for 48 h, with or without hUCMSC-migrasomes (20 µg/mL) pre-treated. After that, cells were collected for the detection of DC maturation markers including CD80, CD86 and MHC-II (n = 3). The representative images for the detection of DC maturation markers are displayed. D Statistical analysis of the mean MFIs of CD80, CD86 and MHC-II of BMDCs (n = 3). E Statistical analysis of the expression of IL-6 in BMDCs by real-time PCR (n = 3). F BMDCs (2 × 104) from WT mice were pre-treated with or without migrasomes and then pulsed with OVA323–339 and LPS and incubated at a 1:5 ratio with splenic CD4+ T cells isolated from OT-II mice (1 × 105) for 72 h. G Statistical analysis of the expression of IL-4, IL-5, IL-13 in collected cell by real-time PCR (n = 3). Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was performed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Stem cell research & therapy

Article Title: Migrasomes derived from human umbilical cord mesenchymal stem cells: a new therapeutic agent for ovalbumin-induced asthma in mice.

doi: 10.1186/s13287-025-04145-4

Figure Lengend Snippet: Fig. 4 HUCMSC-migrasomes impaired DC maturation and function in vitro. A BMDCs incubated with Dil-labeled migrasomes under fluorescence micro scope (white bar = 25 μm). B The cell viability of BMDCs treated by hUCMSC-migrasomes for 24 h (left) and 48 h (right) (n = 4). C BMDCs were isolated from wild-type BALB/c mice and cultured at a density of 2 × 10⁵ cells/mL. The cells were stimulated with OVA (100 µg/mL) and LPS (10 ng/mL) for 48 h, with or without hUCMSC-migrasomes (20 µg/mL) pre-treated. After that, cells were collected for the detection of DC maturation markers including CD80, CD86 and MHC-II (n = 3). The representative images for the detection of DC maturation markers are displayed. D Statistical analysis of the mean MFIs of CD80, CD86 and MHC-II of BMDCs (n = 3). E Statistical analysis of the expression of IL-6 in BMDCs by real-time PCR (n = 3). F BMDCs (2 × 104) from WT mice were pre-treated with or without migrasomes and then pulsed with OVA323–339 and LPS and incubated at a 1:5 ratio with splenic CD4+ T cells isolated from OT-II mice (1 × 105) for 72 h. G Statistical analysis of the expression of IL-4, IL-5, IL-13 in collected cell by real-time PCR (n = 3). Data were presented as mean ± SD. A one-way analysis of variance (Tukey Kramer post hoc tests) was performed on the data. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: The cell pellets were then stained with a range of monoclonal antibodies including FITC anti-mouse CD45 (eBioscience, San Diego, CA), eflour 450 anti-mouse CD4 (eBioscience), PE- anti-mouse CCR4 (Biolegend), APC anti-mouse CXCR3 (Biolegend), eflour 450 anti-mouse CD11c (eBioscience), FITC anti-mouse CD11b (Elabscience, Wuhan, China), PE/Cyanine7 anti-mouse CD80 (Elabscience), PE anti-mouse CD86 (eBioscience) and APC anti-mouse MHC-II (eBioscience).

Techniques: In Vitro, Incubation, Labeling, Fluorescence, Isolation, Cell Culture, Expressing, Real-time Polymerase Chain Reaction

Comparison of the phenotypic profiles of DCLCs primed with or without IFIT4 over-expression. (a) Surface antigens of normal THP-1 cells were examined by flow cytometry. (b) To analyze the effect of IFIT4 on phenotypic changes of dendritic cell-like cells (DCLCs) during the process of differentiation, THP-1 cells were transfected with pEGFP-IFIT4 or pEGFP-C1; 36 hours later, cells were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF; 50 ng/ml) and IL-4 (20 ng/ml) for 90 hours to generate DCLCs. These DCLCs primed with pEGFP-IFIT4 or pEGFP-C1 transfection were incubated with fluorochrome-conjugated monoclonal antibodies (mAbs) and the antigens of CD40, CD80, CD86, CD83, HLA-DR, CD14 and CD1a on the surface of those DCLCs were analyzed by flow cytometry. Appropriate fluorochrome or isotype control mAbs of each antibody species were used as negative controls. Shaded histograms represent isotype control antibodies. The thick line represents DCLCs primed with pEGFP-IFIT4 transfection, whereas the slender lines represent DCLCs primed with pEGFP-C1 transfection. All experiments were performed three times and a set of representative histograms was presented. IFIT4, interferon-induced protein with tetratricopeptide repeats 4.

Journal: Arthritis Research & Therapy

Article Title: Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells

doi: 10.1186/ar2475

Figure Lengend Snippet: Comparison of the phenotypic profiles of DCLCs primed with or without IFIT4 over-expression. (a) Surface antigens of normal THP-1 cells were examined by flow cytometry. (b) To analyze the effect of IFIT4 on phenotypic changes of dendritic cell-like cells (DCLCs) during the process of differentiation, THP-1 cells were transfected with pEGFP-IFIT4 or pEGFP-C1; 36 hours later, cells were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF; 50 ng/ml) and IL-4 (20 ng/ml) for 90 hours to generate DCLCs. These DCLCs primed with pEGFP-IFIT4 or pEGFP-C1 transfection were incubated with fluorochrome-conjugated monoclonal antibodies (mAbs) and the antigens of CD40, CD80, CD86, CD83, HLA-DR, CD14 and CD1a on the surface of those DCLCs were analyzed by flow cytometry. Appropriate fluorochrome or isotype control mAbs of each antibody species were used as negative controls. Shaded histograms represent isotype control antibodies. The thick line represents DCLCs primed with pEGFP-IFIT4 transfection, whereas the slender lines represent DCLCs primed with pEGFP-C1 transfection. All experiments were performed three times and a set of representative histograms was presented. IFIT4, interferon-induced protein with tetratricopeptide repeats 4.

Article Snippet: FITC anti-human CD40 (Catalogue no: FAB617F) and PE anti-human CD80 (Catalogue no: FAB140P) were from R&D Systems, Minneapolis, MN, USA.

Techniques: Comparison, Over Expression, Flow Cytometry, Transfection, Incubation, Bioprocessing, Control

Fig.2 Expression of TPX2 in A549 cells affects macrophage polarization. (A) Detection of macrophage surface markers CD80 and CD163 after cell supernatant induction in A549 group, Vehicle group and TPX2-shRNA group. (B) The analysis percentage of macrophage surface marker CD80, CD163; CD80/CD163 after induction by cell supernatant of the three groups. (C) CD80 and CD163 protein expression in macrophages after induction in the supernatant of the three groups cells. (D) The

Journal: Life sciences

Article Title: TPX2 influences the regulation of macrophage polarization via the NF-κB pathway in lung adenocarcinoma.

doi: 10.1016/j.lfs.2024.122437

Figure Lengend Snippet: Fig.2 Expression of TPX2 in A549 cells affects macrophage polarization. (A) Detection of macrophage surface markers CD80 and CD163 after cell supernatant induction in A549 group, Vehicle group and TPX2-shRNA group. (B) The analysis percentage of macrophage surface marker CD80, CD163; CD80/CD163 after induction by cell supernatant of the three groups. (C) CD80 and CD163 protein expression in macrophages after induction in the supernatant of the three groups cells. (D) The

Article Snippet: THP-1 cell differentiation into macrophages was induced by culturing for 24 h. The supernatant of each group was then applied for 48 h. The induced cells were digested and washed twice, followed by the addition of PE Anti-Human CD80 (B7-1) (PE-65083, Proteintech, China) and APC Anti-Human CD163 (GHI/61) (APC-65169, Proteintech, China) antibodies and resuspended to flow cytometry (BD Biosciences, USA).

Techniques: Expressing, shRNA, Marker